2020-03-29 and 2020-06-28 [
    'Abrilada\xa0(adalimumab-afzb)(b)',
    'Ruxience (rituximab-pvvr)(c)',
    'Vyndamax (tafamidis)',
    'Vyndaqel (tafamidis meglumine)',
    'Zirabev (bevacizumab-bvzr)(d)',
    'Bavencio (avelumab)(a)',
    'Amsparity (adalimumab)(b)',
    'Bevacizumab Pfizer (bevacizumab)(f)',
    'Braftovi (encorafenib)(c)',
    'Daurismo (glasdegib)(g)',
    'Lorviqua (lorlatinib)',
    'Ruxience (rituximab)(a)'
  ]
2020-06-28 and 2020-09-27 : [
    'Abrilada\xa0(adalimumab-afzb)(c)',
    'Amsparity (adalimumab)(c)',
    'Braftovi (encorafenib)(a)',
    'PF-06881894(d)',
    'Rituximab Pfizer (rituximab)(e)',
    'Ruxience (rituximab)(b)',
    'Daurismo (glasdegib)(a)'
]
2020-09-27 and 2021-04-04 : [
    'Abrilada (adalimumab-afzb)(c)',
    'Bavencio (avelumab)',
    'Braftovi (encorafenib)(b)',
    'Nyvepria (pegfilgrastim-apgf)(a)',
    'Xtandi (enzalutamide)',
    'Amsparity (adalimumab)(f)',
    'Bavencio (avelumab)',
    'Bevacizumab Pfizer (bevacizumab)(b)',
    'Braftovi (encorafenib) and Mektovi (binimetinib)',
    'Braftovi (encorafenib)(d)', 
    'Infliximab Pfizer (infliximab)(a)',
    'PF-06881894(g)',
    'Rituximab Pfizer (rituximab)(c)',
    'Ruxience (rituximab)(e)',
    'Staquis (crisaborole)',
    'Vyndaqel (tafamidis free acid)',
    'Xtandi (enzalutamide)',
    'tanezumab',
    'Bavencio (avelumab)',
    'Ibrance (palbociclib)',
    'Talzenna (talazoparib)',
    'Xtandi (enzalutamide)'
]
2021-04-04 and 2021-07-04 : [
    'Bosulif (bosutinib)',
    'Daurismo (glasdegib)',
    'PF-06482077(Vaccine)',
    'Relugolix fixed dose combination(f)',
    'Rituximab Pfizer (rituximab)',
    'Xeljanz (tofacitinib)',
    'abrocitinib (PF-04965842)',
    'somatrogon(PF-06836922)(g)',
    'tanezumab(e)'
]
2021-07-04 and 2021-10-03 : [
    'Bevacizumab Pfizer (bevacizumab)',
    'Infliximab Pfizer (infliximab)',
    'Myfembree(relugolix fixed dose combination)(g)',
    'PF-07302048 (COVID-19 Vaccine)(a)',
    'Prevnar 20(Vaccine)(i)',
    'abrocitinib (PF-04965842)(e)',
    'somatrogon(PF-06836922)(h)',
    'tanezumab(f)'
]
2021-10-03 and 2022-04-03 : [
    'Bavencio (avelumab)(b)',
    'Braftovi (encorafenib) and Mektovi (binimetinib)(c) ',
    'Braftovi (encorafenib)(c) ',
    'Cibinqo (abrocitinib)(e)',
    'Immunization to prevent COVID-19 (booster, adults)',
    'Lorbrena (lorlatinib)',
    'Myfembree(relugolix fixed dose combination)(f)',
    'Nyvepria(pegfilgrastim-apgf)',
    'Prevnar 20(Vaccine)(h)',
    'Xeljanz (tofacitinib)(e)',
    'Xtandi(enzalutamide)(d) ',
    'somatrogon(PF-06836922)(g)'
]
2022-04-03 and 2022-07-03 : []
2022-07-03 and 2022-10-02 : ['Comirnaty/BNT162b2(PF-07302048)(a)', 'Immunization to prevent COVID-19 (12-15 years of age)', 'Immunization to prevent COVID-19 (5-11 years of age)', 'Immunization to prevent COVID-19 (6 months through 4 years of age)', 'Immunization to prevent COVID-19 (booster)', 'Myfembree(relugolix fixed dose combination)(b)', 'Ngenla(somatrogon)(c)', 'Paxlovid(e) (nirmatrelvir [PF-07321332]; ritonavir)', 'Prevnar 20/Apexxnar(Vaccine)(d)', 'Vydura(rimegepant)(f)']
2022-10-02 and 2023-04-02 : ['Cibinqo(abrocitinib)', 'Endometriosis (combination with estradiol and norethindrone acetate)', 'Lorbrena/Lorviqua (lorlatinib)', 'Migraine prevention', 'Myfembree(relugolix fixed dose combination)(a)', 'Xeljanz (tofacitinib)', 'zavegepant(intranasal)']